Andrew Cheng serves as Executive at Akero Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Andrew Cheng has executed 128 insider transactions totaling $26.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 9, 2025 involved selling 277,075 shares valued at $0.
Andrew Cheng currently holds 436,837 shares of Akero Therapeutics, Inc. (AKRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Cheng has been a net seller of AKRO stock. They have purchased $0 and sold $26.8M worth of shares.
Andrew Cheng's most recent insider trade was on Dec 9, 2025, when they sold 277,075 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 20, 2025 | AKRO | $0 | Gift | 74,538 | $N/A | Discretionary |
| Nov 12, 2025 | AKRO | $0 | Gift | 14,739 | $N/A | Discretionary |
| Oct 10, 2025 | AKRO | $1.6M | Sale | 30,000 | $53.98 | Discretionary |
| Oct 10, 2025 | AKRO | $596.1K | Option Exercise | 30,000 | $19.87 | Discretionary |
| Oct 8, 2025 | AKRO | $32.4K | Option Exercise | 52,212 | $0.62 | Discretionary |
| Sep 11, 2025 | AKRO | $77.3K | Sale | 1,796 | $43.02 | Discretionary |
| Sep 10, 2025 | AKRO | $7.0K | Sale | 158 | $44.62 | Discretionary |
| Sep 10, 2025 | AKRO | $82.8K | Option Exercise | 13,022 | $6.36 | Discretionary |
| Sep 10, 2025 | AKRO | $38.1K | Option Exercise | 1,919 | $19.87 | Discretionary |
| Sep 10, 2025 | AKRO | $968.3K | Sale | 22,525 | $42.99 | Discretionary |
| Sep 10, 2025 | AKRO | $321.9K | Sale | 7,317 | $44.00 | Discretionary |
| Aug 11, 2025 | AKRO | $919.0K | Sale | 18,805 | $48.87 | Discretionary |
| Aug 11, 2025 | AKRO | $19.8K | Sale | 400 | $49.44 | Discretionary |
| Aug 11, 2025 | AKRO | $518.9K | Sale | 10,795 | $48.07 | Discretionary |
| Jul 10, 2025 | AKRO | $792.2K | Sale | 15,314 | $51.73 | Discretionary |
| Jul 10, 2025 | AKRO | $742.7K | Sale | 14,686 | $50.57 | Discretionary |
| Jun 30, 2025 | AKRO | $21.2K | Award | 890 | $23.87 | Discretionary |
| Sep 10, 2024 | AKRO | $45.5K | Sale | 1,738 | $26.18 | Discretionary |
| Aug 16, 2024 | AKRO | $15.2K | Option Exercise | 24,538 | $0.62 | Discretionary |
| Jun 28, 2024 | AKRO | $21.2K | Award | 1,064 | $19.94 | Discretionary |
| Jun 11, 2024 | AKRO | $178.7K | Sale | 7,894 | $22.64 | Discretionary |
| Mar 13, 2024 | AKRO | $55.8K | Sale | 1,969 | $28.33 | Discretionary |
| Mar 4, 2024 | AKRO | $4.1K | Sale | 114 | $36.28 | Planned |
| Mar 4, 2024 | AKRO | $283.7K | Sale | 7,995 | $35.49 | Planned |
| Mar 4, 2024 | AKRO | $508.4K | Sale | 14,680 | $34.63 | Planned |
| Mar 4, 2024 | AKRO | $923.7K | Option Exercise | 57,733 | $16.00 | Planned |
| Mar 4, 2024 | AKRO | $218.5K | Sale | 6,770 | $32.28 | Planned |
| Mar 4, 2024 | AKRO | $325.2K | Sale | 9,614 | $33.83 | Planned |